SOLUBLE ST2 AND CD163 AS POTENTIALBIOMARKERS TO DIFFERENTIATE PRIMARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS FROM MACROPHAGE ACTIVATION SYNDROME. Mediterr J Hematol Infect Dis 2019, 11 (1), e2019008. https://doi.org/10.4084/mjhid.2019.008.